Luminex Home

 

 

HomexMAP TechnologySupportCompany

 

 


Collapse All

Expand xMAP Technology
 Support
Expand Our Company
 Contact
 Home
Home > xMAP Technology > Applications > Cancer Markers

 

Cancer Markers

Description
Luminex® xMAP® technology is well-suited for the search for cancer markers, offering multiformat and multiplexing capabilities for identifying either genetic or protein-based markers. In addition to research, xMAP technology is ideal for diagnostic applications in clinical labs, as it allows for multi-analyte profiles with the ability to build internal controls into the various assays. Luminex's breakthrough approach offers comparable sensitivity to traditional ELISA-based systems, but with additional advantages including extended dynamic range and smaller sample size.

AFP (alpha-fetoprotein) Human 
alpha Fetoprotein Human 
CA 125 Human 
CA 15-3 Human 
CA 19-9 Human 
Cancer Antigen 125 Human 
Carcinoembryonic Antigen Human 
CEA (carcinoembryonic antigen) Human 
IGF-II Human 
Leptin Human 
MIF Human 
Osteopontin Human 
Prolactin Human 
PSA, Free Human 

 

xMAP Applications

Allergy Testing  |  Autoimmune  |  Cancer Markers  |  Cardiac Markers  |  Cytokine  |  Endocrine  |  Gene Expression |  Genotyping  |  Infectious Disease  |  Isotyping  |  Kinase/Phosphorylated Protein  |  MMP  |  Metabolic Markers  |  Tissue Typing  |  Transcription Factors/Nuclear Receptors

 

 

 

Home  |  xMAP Technology  |  Support  |  Company  |  Contact   |  Partner Log-in   |  Field Service   

 

© 1997 - 2005 Luminex Corporation  |  Terms and Conditions  |  Disclaimer  |  Privacy Policy